Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

University of Kansas Medical Center Research Institute, Inc

Neither a doctor nor a teaching hospital

Research payments

$528,111

134 payments

Through program year 2025, University of Kansas Medical Center Research Institute, Inc is reported as receiving $528,111 in research payments, across 134 payments.

By program year

6 rows
Year Kind Amount Payments
2025 Research $172,214 18
2024 Research $145,059 36
2023 Research $1,500 1
2021 Research $40,087 4
2020 Research $54,119 2
2019 Research $115,131 73

Breakdown

Who paid Research payments · program years 2019–2025
  1. Flexion Therapeutics, Inc. $180,623 3 payments
  2. Aveo Pharmaceuticals, Inc. $126,021 33 payments
  3. Mesoblast, Inc. $115,112 10 payments
  4. National Marrow Donor Program $43,993 5 payments
  5. Bard Peripheral Vascular, Inc. $23,227 2 payments
  6. Daiichi Sankyo Inc. $13,531 72 payments
  7. Smith+Nephew, Inc. $12,240 7 payments
  8. Immunomedics, Inc. $8,964 1 payment
  9. Sarepta Therapeutics, Inc. $4,400 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. Msb-Dr004 $115,112 10 payments
  2. Zilretta vs. TAcs $101,600 1 payment
  3. An open-label pilot study of the effect of intra-articular bilateral knee injections of Zilretta (FX006) on OARSI recommended physical performance measures in adults with knee osteoarthritis. $79,023 2 payments
  4. TiNivo-2: A Phase 3, Randomized, Controlled, Multicenter, Open-label Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma Who Have Progressed Following One or Two Lines of Therapy Where One Line Has an Immune Checkpoint Inhibitor $41,268 25 payments
  5. A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate/Ruxolitinib versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation $21,493 1 payment
  6. Arch Bdpi-20-004 $16,068 1 payment
  7. Pl3397-A-U126 $13,531 72 payments
  8. Circumferential Compression STITCH Repairs of Complex and Horizontal Cleavage meniscal Tears $12,240 7 payments
  9. A Phase II Trial of Non-Myeloablative Conditioning and Transplantation of Haploidentical Related, Partially HLA-Mismatched, or Matched Unrelated Bone Marrow for Newly Diagnosed Patients with Severe Aplastic Anemia $10,500 1 payment
  10. A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients with Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation $10,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record